Skip to main content Help with accessibility Skip to main navigation

Patient Group Direction

Advance notice

From From 01 October 2024, the national patient group directions (PDGs) for Cheshire and Merseyside will be available on the Cheshire and Merseyside ICB website.

Please bookmark the ICB PGD page now: Patient Group Directions

The PGDs will continue to be available from this legacy Pan Mersey APC website until the end of October.


Maternal Pertussis Vaccination Programme - Important Information

From 1 July 2024, ADACEL (Tdap), a non-IPV-containing vaccine, will replace Boostrix-IPV (dTaP/IPV) for the pertussis vaccination in pregnancy programme.

The ADACEL vaccine, manufactured by Sanofi, was licensed for UK use in 2016. The JCVI recognises the importance of vaccinating pregnant women to protect their babies from pertussis and the advice is clear that Boostrix-IPV vaccine should still be given if ADACEL is not available to avoid delays in vaccination.

A bipartite letter providing key information to both commissioners and healthcare professionals responsible for the delivery of the maternal pertussis vaccination programme is available here:  https://www.gov.uk/government/publications/prenatal-pertussis-vaccine-change-from-july-2024-letter


Document Title
Cheshire and Merseyside Vaccine Patient Group Direction Index - 07/08/2024 08:29:20
Diphtheria, tetanus and inactivated poliomyelitis vaccine, low dose (Td/IPV) - 29/07/2024 10:54:27
Diphtheria, Tetanus, Acellular Pertussis and Inactivated Poliomyelitis Vaccine - 29/07/2024 10:49:26
Diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, Haemophilus influenzae type b and hepatitis B vaccine - 29/07/2024 10:49:26
Haemophilus influenzae type b and meningococcal C conjugate vaccine - 29/07/2024 10:49:26
Haemophilus influenzae type b and meningococcal C conjugate vaccine - extension - 29/07/2024 10:54:53
Hepatitis A and B (Hep A and B) Vaccine - 29/07/2024 10:49:26
Hepatitis A Vaccine - 29/07/2024 10:49:26
Hepatitis B vaccine - 29/07/2024 10:49:26
Hepatitis B vaccine Renal - 29/07/2024 10:49:26
Human papillomavirus vaccine - 29/07/2024 10:54:27
Inactivated influenza vaccine - 29/07/2024 10:54:27
Live attenuated influenza vaccine nasal spray suspension (LAIV) - 29/07/2024 10:54:27
Measles, mumps and rubella vaccine - 29/07/2024 10:54:27
Meningococcal group A, C, W and Y (MenACWY) conjugate vaccine - 29/07/2024 10:54:27
Meningococcal Group A, C, W, and Y Conjugate Vaccine for Risk Groups - 29/07/2024 10:54:27
Meningococcal Group B Vaccine - 29/07/2024 10:54:27
Meningococcal Group B Vaccine Risk Groups - 29/07/2024 10:54:27
Pertussis Vaccine - 29/07/2024 10:54:27
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) - 29/07/2024 10:54:27
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Risk Groups - 29/07/2024 10:54:27
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Risk Groups - extension - 29/07/2024 10:54:27
Pneumococcal polysaccharide vaccine (PPV), 23-valent - 07/08/2024 08:29:44
Respiratory Syncytial Virus (RSV) vaccine - 07/08/2024 08:38:17
Rotavirus vaccine - 29/07/2024 10:54:27
Shingrix® Herpes Zoster Vaccine - 29/07/2024 10:54:27
Typhoid Vi Polysaccharide Vaccine - 29/07/2024 10:54:27
Varicella Vaccine - 29/07/2024 10:54:27
Zostavax - notice of extension of Patient Group Direction validity - 29/07/2024 10:54:27
Zostavax® PGD expiry extensions: Information for healthcare professionals - 29/07/2024 10:54:27
Zostavax® vaccine - 29/07/2024 10:54:27